Clinical Trials Logo

Clinical Trial Summary

We hypothesized that the ability of the Lung Flute to enhance mucus clearance from the lower airways could be used to improve asthma control, if the device is used on a chronic basis. The primary end point of the study is the comparison of Asthma Control Test (ACT) - a validated questionnaire for asthma control and exhaled NO before, during and after using the lung flute. Several secondary end points were assessed for efficacy and safety, including health status, spirometric lung function, "stepping down" controller therapy and daily albuterol use.


Clinical Trial Description

This is a 3 month open label study. We plan to enroll 48 subjects with asthma at the Buffalo General Medical Center Allergy Clinic or the office of Dr. James Cumella. Inclusion criteria includes: at least 12 years of age, diagnosis of asthma and no current or previous history of smoking. Exclusion criteria includes: exacerbation of asthma or hospitalization for asthma within 8 weeks prior to enrollment, predominant chronic obstructive pulmonary disease (COPD) and bronchiectasis by clinical and/or radiological assessment, history of cough syncope, pregnant or nursing women, and inability to comply with study procedures. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02003521
Study type Observational
Source Medical Acoustics LLC
Contact
Status Completed
Phase N/A
Start date November 2013
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT02513160 - Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma Phase 3
Active, not recruiting NCT02883530 - Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
Completed NCT01253603 - Efficacy, Safety, and Pharmacokinetics of QAW039 Phase 2
Completed NCT01845025 - Study of Safety of Foradil in Patients With Persistent Asthma Phase 4
Not yet recruiting NCT02053402 - Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Phase 4
Completed NCT01156844 - Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol Phase 2
Completed NCT01078688 - Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma N/A
Completed NCT02176694 - Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care N/A
Completed NCT02026336 - E-nose and Inflammatory Asthma Phenotypes N/A
Withdrawn NCT04271839 - Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients Phase 4
Active, not recruiting NCT04480242 - Asthma Research in Children and Adolescents
Completed NCT02175771 - Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma Phase 3
Completed NCT01147510 - Asthma Control in Elderly Patients With Montelukast Phase 4
Completed NCT03541187 - Cockroach Immunotherapy in Children and Adolescents Phase 2
Completed NCT02040779 - A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma Phase 3
Active, not recruiting NCT05843045 - Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma N/A